Astal Laboratories Ltd vs Indoco Remedies Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Astal Laboratories Ltd is ₹ 77.28 as of 12 Jun 15:30 . The P/E Ratio of Astal Laboratories Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Indoco Remedies Ltd changed from 28.6 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Astal Laboratories Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Indoco Remedies Ltd changed from ₹ 2658 crore on March 2021 to ₹ 2152 crore on March 2025 . This represents a CAGR of -4.14% over 5 years The revenue of Astal Laboratories Ltd for the Mar '26 is ₹ 134.15 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the growth of 9.2233718E16% The revenue of Indoco Remedies Ltd for the Mar '26 is ₹ 479.31 crore as compare to the Sep '25 revenue of ₹ 485.43 crore. This represent the decline of -1.26% The ebitda of Astal Laboratories Ltd for the Mar '26 is ₹ 10.29 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the growth of 9.2233718E16% The ebitda of Indoco Remedies Ltd for the Mar '26 is ₹ 53.41 crore as compare to the Sep '25 ebitda of ₹ 43.28 crore. This represent the growth of 23.41% The net profit of Astal Laboratories Ltd changed from ₹ 2.74 crore to ₹ 7.68 crore over 5 quarters. This represents a CAGR of 128.08% The net profit of Indoco Remedies Ltd changed from ₹ 1.82 crore to ₹ -23.68 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Astal Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Indoco Remedies Ltd changed from 14.96 % on March 2021 to -21.11 % on March 2025 . This represents a CAGR of NaN% over 5 years .

About Astal Laboratories Ltd

Astal Laboratories Limited was formerly incorporated as a public company limited by shares on August 03, 1993 in the name of Macro International Limited.
The Company was taken over under SEBI takeover guidelines in 2022 and the main objects of the Company was changed to 'Manufacture and Sales of Pharmaceutical Intermediates and Bulk Drugs'.
Subsequently the name of the Company was changed to Astal Laboratories Limited in May, 2024.
The Company is now a subsidiary of Aceso Research Labs LLP. The Company was promoted by the Kanpur based business house of Parasrampurias.
The Company set up a departmental store at Plaza Kalpana, Birhana Road, Kanpur, offering products such as readymade garments, electronic items, leather items, stationery, books, fast food centre etc. During 1996-97, the departmental store project succeeded, only Saree Division and Archies Card Division was in operation.

About Indoco Remedies Ltd

Indoco Remedies Limited, incorporated on August 23, 1947 is a Mumbai-based pharmaceutical company focused on formulations, with some presence in contract manufacturing and research.
The Company headquartered in Mumbai, is a fully integrated, research-oriented pharma Company with presence in 55 countries.
The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). Indoco, a USD 212 million company has 11 manufacturing facilities, 7 of which are for FDFs and 4 for APIs, supported by a state-of-the-art R&D Centre and a CRO facility. Currently, Indoco has a presence in therapeutic segments including anti-infective, anti-cold preparation, opthalmic, antispasmodic, stomatology, anti-inflammatory and anti-fungal.

FAQs for the comparison of Astal Laboratories Ltd and Indoco Remedies Ltd

Which company has a larger market capitalization, Astal Laboratories Ltd or Indoco Remedies Ltd?

Market cap of Astal Laboratories Ltd is 338 Cr while Market cap of Indoco Remedies Ltd is 2,297 Cr

What are the key factors driving the stock performance of Astal Laboratories Ltd and Indoco Remedies Ltd?

The stock performance of Astal Laboratories Ltd and Indoco Remedies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Astal Laboratories Ltd and Indoco Remedies Ltd?

As of June 14, 2026, the Astal Laboratories Ltd stock price is INR ₹77.28. On the other hand, Indoco Remedies Ltd stock price is INR ₹248.95.

How do dividend payouts of Astal Laboratories Ltd and Indoco Remedies Ltd compare?

To compare the dividend payouts of Astal Laboratories Ltd and Indoco Remedies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.